A Phase I, Randomized, Multi‐Dose Study to Evaluate the Enteric Selectivity and Safety of JAK Inhibitor, Lorpucitinib, in Healthy Participants

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Xuewen Ma, Gary Borzillo, Martine J. Christine Kothe, Madhu Sanga, Gerald Chu, James G. Greger, Annemie Deiteren, Edward Attiyeh
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Clinical Pharmacology & Therapeutics
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet